A Phase 1 Trial of Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer After Brachytherapy

Autor: Patel, Krishnan R. ^*, Rydzewski, Nicholas R. ^*, Schott, Erica ^*, Cooley-Zgela, Theresa ^*, Ning, Holly ^*, Cheng, Jason ^*, Salerno, Kilian ^*, Huang, Erich P., Lindenberg, Liza, Mena, Esther, Choyke, Peter, Turkbey, Baris, Citrin, Deborah E. ^*

Publikováno v: In International Journal of Radiation Oncology, Biology, Physics 1 August 2024 119(5):1471-1480

Detection of failure patterns using advanced imaging in patients with biochemical recurrence following low-dose-rate brachytherapy for prostate cancer

Autor: Salerno, Kilian E., Turkbey, Baris, Lindenberg, Liza, Mena, Esther, Schott, Erica E., Brennan, Alexandra K., Roy, Soumyajit, Shankavaram, Uma, Patel, Krishnan, Cooley-Zgela, Theresa, McKinney, Yolanda, Wood, Bradford J., Pinto, Peter A., Choyke, Peter, Citrin, Deborah E.

Publikováno v: In Brachytherapy July-August 2022 21(4):442-450

A Phase 1 Trial of Image Guided Risk Volume-Adapted Postprostatectomy Radiation Therapy

Autor: Patel, Krishnan R. ^*, Mena, Esther, Rowe, Lindsay S., Ning, Holly ^*, Cheng, Jason ^*, Salerno, Kilian ^*, Schott, Erica ^*, Nathan, Debbie-Ann ^*, Huang, Erich P., Lindenberg, Liza, Choyke, Peter, Turkbey, Baris, Citrin, Deborah E. ^*

Publikováno v: In International Journal of Radiation Oncology, Biology, Physics September 2024

A Phase 1 Trial of Highly Conformal, Hypofractionated Postprostatectomy Radiation Therapy.

Autor: Patel KR; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Rowe LS; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Schott E; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Cooley-Zgela T; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Ning H; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Turkbey B; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Choyke P; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Lindenberg L; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Mena E; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Pinto PA; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Zhang Q; Division of Cancer Treatment and Diagnosis: Biometric Research Program, National Cancer Institute, National Institutes of Health, Rockville, Maryland., Shih J; Division of Cancer Treatment and Diagnosis: Biometric Research Program, National Cancer Institute, National Institutes of Health, Rockville, Maryland., Salerno KE; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Citrin DE; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Publikováno v: Advances in radiation oncology [Adv Radiat Oncol] 2022 Jul 15; Vol. 7 (6), pp. 101024. Date of Electronic Publication: 2022 Jul 15 (Print Publication: 2022).

Local failure after definitive radiation treatment of lymph-node positive prostate cancer: supporting the use of novel imaging techniques to personalize treatment options.

Autor: Chaurasia AR; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Smith CP; Georgetown University School of Medicine, Washington, DC, USA., Pinto P; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Wood B; Center for Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Schott E; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Cooley-Zgela T; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Madan R; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Lindenberg L; Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Mena E; Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Choyke P; Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Citrin D; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Turkbey B; Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Publikováno v: BJR case reports [BJR Case Rep] 2020 Apr 17; Vol. 6 (3), pp. 20200001. Date of Electronic Publication: 2020 Apr 17 (Print Publication: 2020).